Q32 Bio
QTTB
QTTB
71 hedge funds and large institutions have $15.5M invested in Q32 Bio in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
-19
Holders Change %
-21.11%
% of All Funds
0.96%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
8
Increased
17
Reduced
20
Closed
26
Calls
$1K
Puts
$8K
Net Calls
-$7K
Net Calls Change
+$429K
Top Buyers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$68.1K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$50K |
| 3 |
Goldman Sachs
New York
|
+$42.8K |
| 4 |
State Street
Boston,
Massachusetts
|
+$36.2K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.8K |
Top Sellers
| 1 |
SCM
Sio Capital Management
New York
|
-$2.4M |
| 2 |
Temasek Holdings
Singapore
|
-$1.08M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$280K |
| 4 |
Two Sigma Investments
New York
|
-$183K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$173K |
